Skip to main content

Tauriga Sciences, Inc. Reports Continued Surge in its E-Commerce Business Segment

Written by Customer Service on . Posted in Public Companies.


On Sunday March 29, 2020 – The Company Set New Daily Records for: Revenue Generated and Number of Individual TransactionsNEW YORK, NY, March 30, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today confirmed that its E-Commerce business segment is continuing to show strength and rapid growth.  On Sunday March 29, 2020, the Company set new daily records for both its E-Commerce revenue generated as well as number of individual transactions. For the first time, the Company generated in excess of $4,000 in daily E-Commerce revenue.  The E-Commerce business segment, is by far, the Company’s highest margin source of revenue.     In other news, the Company has committed to donate 25 cents (“$0.25”) per Tauri-Gum™ Blister Pack sold (exclusively pertaining to its E-Commerce business), to the United Way COVID-19 Community Response and Recovery Fund.  This commitment will be valid for the following period: April 1, 2020 – December 31, 2020. An initial contribution from the Company has already been processed.   ABOUT TAURIGA SCIENCES INC.Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE.  During December of 2019, the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gum drop”), branded under the name: Tauri-Gummies™.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model.  The Company has also announced the development of a Cannabigerol (“CBG”) Isolate infused version of Tauri-Gum™.  The flavor that has been selected is Peach-Lemon and each piece of gum contains 10mg of CBG Isolate / Each blister pack contains 80mg of CBG Isolate.  The Company announced, on March 24, 2020, that it completed payment for the entirety of its initial production run of its CBG version of Tauri-Gum™ (commercial launch – April 2020).  Please visit our corporate website at www.tauriga.com.In addition – During March 2019, the Company announced the official launch of its E-Commerce site – as part of its Tauri-Gum™ commercialization strategy.  This site can be accessed by visiting the following URL address:  www.taurigum.comOn January 13, 2020, the Company formed a wholly owned subsidiary called: Tauriga Pharma Corp.  This subsidiary is focused on the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment(s)).  On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.The Company has established corporate offices in both New York City (USA) and Barcelona (Spain) and operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER — Forward-Looking StatementsContact:CONTACT INFORMATION

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.